Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Zablocki

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 19, 2006
N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonistsElfatih Elzein, Rao Kalla, Xiaofen Li, et al.
Journal of Medicinal Chemistry|June 9, 2006
Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonistsRao V Kalla, Elfatih Elzein, Thao Perry, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 21, 2007
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonistsMing Yang, Daniel Soohoo, Sandriyana Soelaiman, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonistsElfatih Elzein, Rao Kalla, Xiaofen Li, et al.
British Journal of Pharmacology|July 25, 2016
The novel late Na<sup>+</sup> current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparationsSridharan Rajamani, Gongxin Liu, Nesrine El-Bizri, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Novel inhibitors of fatty acid oxidation as potential metabolic modulatorsElfatih Elzein, Kevin Shenk, Prabha Ibrahim, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthmaJeff Zablocki, Rao Kalla, Thao Perry, et al.
Nature Medicine|August 24, 2010
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesisLina Yao, Peidong Fan, Maria Arolfo, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitorsDmitry O Koltun, Timur M Zilbershtein, Vasily A Migulin, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitorsDmitry O Koltun, Eric Q Parkhill, Natalya I Vasilevich, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|October 19, 2006
N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonistsElfatih Elzein, Rao Kalla, Xiaofen Li, et al.
Journal of Medicinal Chemistry|June 9, 2006
Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonistsRao V Kalla, Elfatih Elzein, Thao Perry, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 21, 2007
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonistsMing Yang, Daniel Soohoo, Sandriyana Soelaiman, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonistsElfatih Elzein, Rao Kalla, Xiaofen Li, et al.
British Journal of Pharmacology|July 25, 2016
The novel late Na<sup>+</sup> current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparationsSridharan Rajamani, Gongxin Liu, Nesrine El-Bizri, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Novel inhibitors of fatty acid oxidation as potential metabolic modulatorsElfatih Elzein, Kevin Shenk, Prabha Ibrahim, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthmaJeff Zablocki, Rao Kalla, Thao Perry, et al.
Nature Medicine|August 24, 2010
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesisLina Yao, Peidong Fan, Maria Arolfo, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitorsDmitry O Koltun, Timur M Zilbershtein, Vasily A Migulin, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitorsDmitry O Koltun, Eric Q Parkhill, Natalya I Vasilevich, et al.
Pageof 3